SporeGen

SporeGen® and Nam Khoa Biotek Co. Ltd to develop a novel treatment for gastrointestinal disease

  • May 18, 2017
  • SporeGen

SporeGen® and Nam Khoa Biotek Co. Ltd (Ho Chi Minh City, Vietnam) have finalised a co-operative agreement to develop a novel treatment for Vietnam’s no. 1 gastrointestinal disease.



IMG20170504143224.jpg#asset:250


IMG20170504100118.jpg#asset:249